22 studies found for:    ALIAS
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
Condition: Essential Hypertension
Interventions: Drug: Aliskiren;   Drug: Ramipril;   Drug: Matching placebo to Aliskiren;   Drug: Matching placebo to Ramipril
2 Terminated Albumin in Acute Ischemic Stroke Trial
Condition: Acute Ischemic Stroke
Interventions: Biological: human serum albumin infusion;   Drug: placebo
3 Recruiting Transient Infrared Imaging for Early Detection of Skin Cancer
Condition: Skin Cancer
Intervention: Device: Infrared Imaging Device- ALIAS
4 Completed
Has Results
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: CP-690,550 Eye drops;   Drug: CP-690,550 Eye drops-vehicle;   Drug: Sodium Hyaluronate
5 Unknown  AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
Condition: Systemic Sclerosis
Interventions: Drug: Hyperimmune caprine serum;   Drug: Albumin
6 Unknown  Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)
Conditions: Nervous System Disorder;   Imbalance of Constituents of Food Intake
Interventions: Dietary Supplement: asn01;   Other: Placebo
7 Completed
Has Results
A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA
Condition: Rheumatoid Arthritis
Intervention: Drug: Etanercept
8 Unknown  Body Movement Imitation and Perspective Perception Among Psychiatric Patients
Conditions: Schizophrenia;   Depression
Intervention: Device: imitation assessment using the 5-dt "data glove".
9 Completed Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide
Condition: Hypoglycemia
Intervention: Dietary Supplement: FOS
10 Completed Evaluating the Health Benefits of Workplace Policies and Practices - Phase II
Condition: Focus of Study: Work Conditions
Intervention: Behavioral: Intervention
11 Recruiting Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes
Condition: Malnutrition
Interventions: Dietary Supplement: New DELICAL formula;   Dietary Supplement: Standard DELICAL formula
12 Unknown  Naturlose (D-Tagatose) Efficacy Evaluation Trial
Condition: Type 2 Diabetes
Interventions: Drug: Tagatose;   Drug: Placebo
13 Active, not recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Condition: Arthritis, Rheumatoid
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
14 Completed
Has Results
Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
Condition: Genital Herpes
Interventions: Drug: Famciclovir;   Drug: Placebo
15 Recruiting Randomized Clinical Trial of RN316 (PF-04950615) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Condition: Hyperlipidemia
Interventions: Drug: PF-04950615;   Other: Placebo
16 Completed Second Generation Surveillance Methods To Prevent Thrombosis And Increase Assisted Primary Patency Survival In Native Arteriovenous Fistulae
Condition: Thrombosis in Native Arteriovenous Fistulae.
Interventions: Device: Second generation surveillance of AVF;   Procedure: vital signs;   Procedure: physical examination of AVF;   Procedure: ktv test;   Procedure: urea method
17 Recruiting Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation
Conditions: Acute Respiratory Failure;   Treatment With Noninvasive Positive Pressure Ventilation
Interventions: Device: High-flow humidified nasal oxygen delivery system;   Device: Standard oxygen therapy
18 Recruiting Treatment of Dyspnea in Do-not-intubate Patients
Conditions: Acute Respiratory Failure;   Acute on Chronic Respiratory Failure;   Dyspnea
Interventions: Device: NIV;   Device: CPAP;   Device: Standard oxygen;   Device: HFNC
19 Unknown  Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Risk;   Endothelial Dysfunction
Intervention:
20 Recruiting Ovarian Dendritic Cell Vaccine Trial
Condition: Ovarian Cancer
Interventions: Biological: Ontak DC;   Biological: DC vaccination;   Drug: Ontak

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years